High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Mise à jour : Il y a 4 ans
Référence : NCT00662220

Femme et Homme

  • | Pays :
  • Netherlands
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Optimal ribavirin dosages are essential in achieving SVR (sustained virological response). Several studies have shown higher SVR rates in patients receiving higher doses of ribavirin. Therefore we propose a randomized controlled open label multicenter trial to investigate wether high (25-29mg/kg) dose ribavirin can improve outcome in patients in infected with hepatitis C virus genotype 1 or 4 compared to standard dose (12-15mg/kg).


Critère d'inclusion

  • Chronic hepatitis C